Kymera Therapeutics, Inc. - KYMR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 5.5% | 4,412,933 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 5.5% | 4,412,933 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 5.5% | 4,412,933 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Company LLP | 5.3% | 4,412,933 | View |
| Jan 08, 2026 | SCHEDULE 13G/A | FMR LLC | 11.2% | 8,928,574 | View |
| Jan 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 11.2% | 8,928,574 | View |
| Dec 15, 2025 | SCHEDULE 13D/A | — | 4.4% | 63,667,671 | View |
| Dec 11, 2025 | SCHEDULE 13D/A | — | 19.99% | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 7.1% | 5,097,704 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 8.2% | 5,879,611 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 8.2% | 5,879,611 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.